THE TGA has responded to Pharmacy Daily's request for comment on benzene contamination of acne products (PD 17 Mar), stating: "The TGA is aware of the recent US recall of benzoyl peroxide-based acne treatments due to elevated levels of benzene, and is currently considering what regulatory action, if any, should be taken in Australia."
The above article was sent to subscribers in Pharmacy Daily's issue from 18 Mar 25
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 18 Mar 25
